reference/2432680

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/2432680

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	184
issn	1744-6872
issueIdentifier	4
pageRange	179-184
publicationName	Pharmacogenetics and Genomics
startingPage	179
bibliographicCitation	Wehland M, Bauer S, Brakemeier S, Burgwinkel P, Glander P, Kreutz R, Lorkowski C, Slowinski T, Neumayer HH, Budde K. Differential impact of the CYP3A51 and CYP3A53 alleles on pre-dose concentrations of two tacrolimus formulations. Pharmacogenet Genomics. 2011 Apr;21(4):179–84. doi: 10.1097/fpc.0b013e32833ea085. PMID: 20818295.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_04a4e6169874320fe55d62819cb92fd7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-8160-859X http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1e94d09b2907c6eca7d7429d6b25b9dc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_71f8b25ba709b6666dd850c0dd148bae http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5c397d927687dd8228abcd53199184a2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-7380-2985 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-4818-211X http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a33d441d9a8d21ab708dbbcb3c5223f5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1bd70164b98a83193ebb7e41f6c750c6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_315fb2525440869dcd7b3366a844e0e0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2c694b0083c838d0c9fcfef87a64547d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_72dea5a55fe85991d1cd57d7703397e0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-7929-5942 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ddcac07e022ad7745ff216722abbb17f
date	201104
identifier	https://doi.org/10.1097/fpc.0b013e32833ea085 https://pubmed.ncbi.nlm.nih.gov/20818295
isPartOf	https://portal.issn.org/resource/ISSN/1744-6872 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/32413
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Differential impact of the CYP3A51 and CYP3A53 alleles on pre-dose concentrations of two tacrolimus formulations
discusses	http://id.nlm.nih.gov/mesh/M0025261 http://id.nlm.nih.gov/mesh/M0272854 http://id.nlm.nih.gov/mesh/M0011171 http://id.nlm.nih.gov/mesh/M0082919
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D016559Q000493 http://id.nlm.nih.gov/mesh/D007166Q000493 http://id.nlm.nih.gov/mesh/D051544Q000235 http://id.nlm.nih.gov/mesh/D000483
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D005838 http://id.nlm.nih.gov/mesh/D011110 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D015331
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445643 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8535dce74a282d4ae5610eb102d132e9

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1577 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID242963342

Total number of triples: 51.